ACAD
29.24
+0.56
+1.95%
AEMD
2.13
-0.2
-8.58%
APRI
1.16
+0.07
+6.42%
ARNA
14.88
-1.31
-8.09%
ATEC
1.88
+0.02
+1.08%
CNAT
5.1
+0.14
+2.82%
CRXM
0.175
+0.00
+0.1719%
CYTX
1.04
0.00
0.00%
DXCM
77.33
-1.35
-1.72%
GNMK
12.75
+0.1
+0.79%
HALO
14.89
+0.06
+0.40%
ILMN
185.28
+2.29
+1.25%
INNV
0.12
+0.01
+9.55%
INO
8.2
+0.12
+1.49%
ISCO
1.15
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
123.87
+0.74
+0.60%
LPTN
2.93
-0.08
-2.66%
MBVX
1.538
+0.068
+4.5918%
MEIP
2.3
+0.14
+6.48%
MNOV
5.54
-0.02
-0.36%
MRTX
3.8
-0.25
-6.17%
MSTX
0.131
-0.007
-5.278%
NBIX
47.35
+0.23
+0.49%
NUVA
76.78
-0.13
-0.17%
ONCS
1.07
-0.07
-6.14%
ONVO
2.76
+0.05
+1.85%
OREX
3.12
+0.03
+0.97%
OTIC
18.75
+1
+5.63%
QDEL
27.38
+0.89
+3.36%
RCPT
231.96
0.00
0.00%
RGLS
0.915
-0.075
-7.576%
RMD
78.44
+0.81
+1.04%
SCIE
0
0.00
0.00%
SPHS
2.06
0.00
0.00%
SRNE
1.85
-0.1
-5.13%
TROV
1.14
-0.16
-12.31%
VICL
2.45
-0.03
-1.21%
VOLC
18
0.00
0.00%
ZGNX
15
0.00
0.00%
ACAD
29.24
+0.56
+1.95%
AEMD
2.13
-0.2
-8.58%
APRI
1.16
+0.07
+6.42%
ARNA
14.88
-1.31
-8.09%
ATEC
1.88
+0.02
+1.08%
CNAT
5.1
+0.14
+2.82%
CRXM
0.175
+0.00
+0.1719%
CYTX
1.04
0.00
0.00%
DXCM
77.33
-1.35
-1.72%
GNMK
12.75
+0.1
+0.79%
HALO
14.89
+0.06
+0.40%
ILMN
185.28
+2.29
+1.25%
INNV
0.12
+0.01
+9.55%
INO
8.2
+0.12
+1.49%
ISCO
1.15
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
123.87
+0.74
+0.60%
LPTN
2.93
-0.08
-2.66%
MBVX
1.538
+0.068
+4.5918%
MEIP
2.3
+0.14
+6.48%
MNOV
5.54
-0.02
-0.36%
MRTX
3.8
-0.25
-6.17%
MSTX
0.131
-0.007
-5.278%
NBIX
47.35
+0.23
+0.49%
NUVA
76.78
-0.13
-0.17%
ONCS
1.07
-0.07
-6.14%
ONVO
2.76
+0.05
+1.85%
OREX
3.12
+0.03
+0.97%
OTIC
18.75
+1
+5.63%
QDEL
27.38
+0.89
+3.36%
RCPT
231.96
0.00
0.00%
RGLS
0.915
-0.075
-7.576%
RMD
78.44
+0.81
+1.04%
SCIE
0
0.00
0.00%
SPHS
2.06
0.00
0.00%
SRNE
1.85
-0.1
-5.13%
TROV
1.14
-0.16
-12.31%
VICL
2.45
-0.03
-1.21%
VOLC
18
0.00
0.00%
ZGNX
15
0.00
0.00%
Home » Archive by Category

Xconomy

Mary Lou Jepsen, Moonshots, and the Human Impact of Innovation

March 29, 2017 – 7:19 am

As expressions go, “moonshot” has recently been gaining a lot of popularity in the media vernacular. Many folks assume that it arose with NASA’s Apollo 11 mission to the moon. But it’s a matter of…

[[Click headline to continue reading.]]

ViaCyte Working with Gore to Improve its Synthetic Pancreas Device

March 29, 2017 – 5:00 am

San Diego-based ViaCyte said today it is collaborating with W.L. Gore & Associates, the privately held company that makes Gore-Tex fabrics, medical devices, and other products, in a bid to…

[[Click headline to continue reading.]]

Ionis Pharma Spins Out Lipid Disorder Unit Akcea with Plans for IPO

March 27, 2017 – 7:35 am

Akcea Therapeutics, an Ionis Pharmaceuticals subsidiary focused on rare lipid disorders, is spinning out of its parent with plans for an initial public stock offering as it prepares to file for FDA…

[[Click headline to continue reading.]]

Bio Roundup: Trumpcare Wavers, Amgen Courts Payers, Critics Circle PTC

March 24, 2017 – 3:25 am

Who knew healthcare could be so complicated? This week, President Trump and the GOP saw first hand, as a feverish rally to get their healthcare bill through the House of Representatives on Thursday…

[[Click headline to continue reading.]]

Today Only: Save $70 for Human Impact of Innovation on April 19th

March 23, 2017 – 2:45 am

Xconomy is convening life sciences and technology founders, executives, investors, and entrepreneurs for an afternoon of fireside chats and solo talks at Human Impact of Innovation. A few topics…

[[Click headline to continue reading.]]

Amid Gender Gap Talk, Mentor Network Emerges For Women In Health, Bio

March 23, 2017 – 2:30 am

It’s been more than a year since an infamous party with hired models in cocktail dresses captured the biotech community’s attention at the 2016 J.P. Morgan conference. There has been…

[[Click headline to continue reading.]]

Join David Baltimore, Nicole Glaros, Nathan Myhrvold, & More at Our Napa Summit

March 22, 2017 – 3:15 am

Year after year, Xconomy has gathered exemplary business leaders, investors, and far-seeing technologists to our most prestigious event—The Napa Summit. This year is no different. Come join us…

[[Click headline to continue reading.]]

Waving White Flag, Cerulean Merges With Dare Bio, Sells Cancer Drugs

March 20, 2017 – 6:41 am

Cerulean Pharma may have been able to survive one brush with death, but the second has proven fatal. Today, the Waltham, MA, company announced plans to merge with a privately held women’s health…

[[Click headline to continue reading.]]

With New Data, Amgen Promises Refund If Cholesterol Drug Doesn’t Work

March 17, 2017 – 4:55 am

Stung by slow sales of its next-generation anti-cholesterol drug, Amgen hopes new clinical data, released this morning, will spur doctors to boost prescriptions and—perhaps more…

[[Click headline to continue reading.]]

Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More

March 17, 2017 – 2:50 am

If it wasn’t clear that the Trump administration disdained most types of scientific inquiry and practice, the White House’s proposed budget drove the point home. The top-line figures: a…

[[Click headline to continue reading.]]